VANCOUVER, BRITISH COLUMBIA -- (MARKET WIRE) -- February 13, 2007 -- Pyng Medical Corp. (TSX VENTURE: PYT) is pleased to announce it has engaged StarFish Medical to design and develop the next generation of the FAST1™ Intraosseous Infusion System. FAST1™ is the only intraosseous infusion device able to provide rapid sternal access and delivery of life saving fluids and drugs to the heart of critically injured patients in seconds. "Pyng is committed to advancing and expanding our family of intraosseous infusion systems to address our expanding critical care markets in military, hospital, and emergency medical services," stated David Christie, President and CEO of Pyng.
